$275 Million is the total value of Essex Woodlands Management, Inc.'s 10 reported holdings in Q3 2014. The portfolio turnover from Q2 2014 to Q3 2014 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
RVNC | REVANCE THERAPEUTICS INC | $88,764,000 | -43.1% | 4,592,047 | 0.0% | 32.32% | -0.5% | |
ABMD | ABIOMED INC | $78,214,000 | -1.2% | 3,150,000 | 0.0% | 28.48% | +72.9% | |
CORI | CORIUM INTL INC | $57,429,000 | -21.0% | 9,353,304 | 0.0% | 20.91% | +38.3% | |
ACUR | ACURA PHARMACEUTICALS INC | $7,629,000 | -28.4% | 10,284,886 | 0.0% | 2.78% | +25.3% | |
ZIOP | ZIOPHARM ONCOLOGY INC | $7,130,000 | -30.5% | 2,764,908 | 0.0% | 2.60% | +21.7% | |
MNOV | MEDICINOVA INC | $3,499,000 | +47.3% | 1,170,370 | 0.0% | 1.27% | +157.9% | |
CRIS | CURIS INC | $330,000 | -24.1% | 233,797 | 0.0% | 0.12% | +33.3% | |
PTN | PALATIN TECHNOLOGIES INC | $23,000 | -4.2% | 23,928 | 0.0% | 0.01% | +60.0% | |
ECTE | ECHO THERAPEUTICS INC | $10,000 | -64.3% | 12,319 | 0.0% | 0.00% | -33.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MEDICINOVA INC | 42 | Q3 2023 | 6.5% |
REVANCE THERAPEUTICS INC | 39 | Q3 2023 | 44.6% |
AXOGEN INC | 26 | Q4 2021 | 43.3% |
ENDOLOGIX INC | 24 | Q1 2019 | 22.5% |
ABIOMED INC | 20 | Q1 2018 | 52.1% |
CORIUM INTL INC | 20 | Q1 2019 | 23.5% |
TELA BIO, INC. | 16 | Q3 2023 | 31.5% |
VENUS CONCEPT, INC. | 16 | Q3 2023 | 21.3% |
ACURA PHARMACEUTICALS INC | 15 | Q1 2019 | 1.4% |
CATALYST BIOSCIENCES INC | 15 | Q1 2019 | 1.0% |
View Essex Woodlands Management, Inc.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
View Essex Woodlands Management, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.